LIFITEGRAST 5% FOR DRY EYE DISEASE: COMBINED EFFICACY AND SAFETY FROM FIVE RANDOMIZED CONTROLLED TRIALS

Five randomized, double-masked, placebo-controlled trials were conducted in the US in adults with DED, an eye dryness score (EDS, visual analogue scale [VAS], 0–100) ≥40, and inferior corneal staining score ([ICSS], 0-4) ≥2.0 at study entry: four 84-day efficacy trials (phase 2, lifitegrast n=58, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Agustin L, Donnenfeld, Eric, Baudouin, Christophe, Holland, Edward, Nichols, Kelly, Karpecki, Paul, Hamdani, Mohamed, Shojaei, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Session 1320 (Poster)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6846150/
http://dx.doi.org/10.1093/geroni/igz038.983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6846150/
http://dx.doi.org/10.1093/geroni/igz038.983

Ejemplares similares